A law firm has launched an investigation on the behalf of investors of Aspect Medical Systems, Inc. into the Board approved takeover price during the sale of the company to Covidian.
The investigation is looking into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Aspect. The law firm’s investigation states, “the transaction appears to be unfair” to current investors of Aspect Medical Systems, Inc. because the “offer to purchase Aspect Medical Systems, Inc. at $12 per share appears opportunistically timed to take advantage of the current economic downturn”.
· Related: Covidien Ltd.
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto
Advertisement